1. Companies

  2. Brainsway

Brainsway

Brainsway

Verified
Brainsway is the developer of Deep Transcranial Magnetic Stimulation (TMS) Therapy, a patented, noninvasive, FDA-cleared solution for treating depressive episodes in adult patients suffering from major depressive disorder who have failed to achieve s.
Launch date
Employees
51-200 people
Market cap
$91.2m
Net debt
$45.5m
Enterprise valuation
$46m (Public information from May 2024)
Burlington Massachusetts (HQ)
http://www.brainsway.com
https://twitter.com/brainswayhttps://www.facebook.com/brainswaydeeptmshttps://www.linkedin.com/company/brainswayhttps://apps.apple.com/app/id1448673842

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
USD2019202020212022202320242025
Revenues0000000000000000000000000000
% growth41 %(5 %)34 %(8 %)17 %19 %17 %
EBITDA0000000000000000000000000000
% EBITDA margin(28 %)(22 %)(11 %)(41 %)(8 %)--
Profit0000000000000000000000000000
% profit margin(45 %)(24 %)(22 %)(49 %)(13 %)--
EV / revenue00.0x00.0x00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x00.0x00.0x
R&D budget0000000000000000000000000000
R&D % of revenue34 %26 %22 %28 %21 %--
    • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor investor

$0.0

round
N/A

$0.0

round
N/A

$45.2m

Post IPO Equity
Total Funding000k

RELATED LANDSCAPES AND LISTS

Related Content

Recent News about Brainsway

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.